Emily Bodnar

H.C. Wainwright & Co.

Recent Articles

Biotech Co. Still a Buy Despite Manufacturing Setbacks 07/07/2025

While it received a lower price target due to manufacturing setbacks, Jasper Therapeutics Inc. (JSPR:NASDAQ) is still a Buy, according to an H.C. Wainwright & Co. research note.

Intratubal Insemination Device Shown Effective, Safe 12/03/2024

Pregnancy rates with this "only new innovation for infertility in decades" were "impressive" in a pivotal study in women with male factor infertility, noted an H.C. Wainwright & Co. report.